RyeBrowne02
(Newbie)
*

Registration Date: 06-02-2018
Date of Birth: February 7
Local Time: 11-19-2018 at 12:42 PM
Status:

RyeBrowne02's Forum Info
Joined: 06-02-2018
Last Visit: (Hidden)
Total Posts: 0 (0 posts per day | 0 percent of total posts)
(Find All Posts)
Total Threads: 0 (0 threads per day | 0 percent of total threads)
(Find All Threads)
Time Spent Online: (Hidden)
Reputation: 0 [Details]

RyeBrowne02's Contact Details
AIM Screen Name: https://farmatrade.eu
  
Additional Info About RyeBrowne02
Bio: Ask your healthcare provider or pharmacist if you are not sure if any of your medicines are nitrates or guanylate cyclase stimulators, such as riociguat. Medicines called nitrates include nitroglycerin that is found in tablets, sprays, ointments, pastes, or patches. Read this important information before you start taking CIALIS and each time you get a refill.

In this study, the effect of CIALIS 5 mg once daily on Qmax was evaluated as a safety endpoint. CIALIS 5 mg for once daily use also resulted in statistically significant improvement in SEP3. CIALIS 5 mg for once daily use resulted in statistically significant improvements in the total IPSS and in the EF domain of the IIEF questionnaire.

CIALIS 5 mg For Once Daily Use For ED And BPH. In the 404 patients who had both ED and BPH at baseline, changes in erectile function were assessed as key secondary endpoints using the EF domain of the IIEF questionnaire. However, the magnitude of the treatment difference between placebo/finasteride and CIALIS/finasteride decreased from 1.7 points at Week 4 to 1.0 point at Week 26, as shown in Table 20 and in Figure 7. The incremental benefit of CIALIS beyond 26 weeks is unknown.

CIALIS for once daily use initiated together with finasteride was shown to be effective in treating the signs and symptoms of BPH in men with an enlarged prostate (>30 cc) for up to 26 weeks. Efficacy Results In Patients With BPH Initiating CIALIS And Finasteride. Mean Qmax increased from baseline in both the treatment and placebo groups (CIALIS 5 mg: 1.6 mL/sec, placebo: 1.1 mL/sec); however, these changes were not significantly different between groups.

In Study K, the effect of CIALIS 5 mg once daily on Qmax was evaluated as a safety endpoint. Mean Qmax increased from baseline in both the treatment and placebo groups (CIALIS 5 mg: 1.6 mL/sec, placebo: 1.2 mL/sec); however, these changes were not significantly different between groups. In Study J, the effect of CIALIS 5 mg once daily on maximum urinary flow rate (Qmax) was evaluated as a secondary efficacy endpoint.

In each of these 2 trials, CIALIS 5 mg for once daily use resulted in statistically significant improvement in the total IPSS compared to placebo. CIALIS 5 mg For Once Daily Use For Benign Prostatic Hyperplasia (BPH) In this third trial, CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 18).

When taken as directed, CIALIS was effective at improving erectile function. At the 36-hour timepoint, the mean, per-patient percentage of attempts resulting in successful intercourse were 33, 56, and 62% for placebo, CIALIS 10-, and 20-mg groups, respectively. At the 24-hour timepoint, the mean, per patient percentage of attempts resulting in successful intercourse were 42, 56, and 67% for the placebo, CIALIS 10-, and 20-mg groups, respectively.
<a href="https://farmatrade.eu">https://farmatrade.eu</a>
Sex: Other

Disclaimer : All messages made available as part of this forum, including opinions, advice, statements or other information contained in any messages posted or transmitted by any third party are the responsibility of the author of that message and do not necessarily reflect the views and policies of HUD or the U.S. Government. HUD cannot attest to the accuracy, completeness or usefulness of any messages. This is a monitored forum; posts are subject to approval.